 |
264 Diseases |  |
12 Trials |
|
12 Trials |  |
579 News |  |
| «12345678 |
- Zarnestra (tipifarnib) / Kura Oncology, Herceptin (trastuzumab) / Roche
Trial withdrawal: Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer (clinicaltrials.gov) - Jun 26, 2012
P2, N=0, Withdrawn, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Withdrawn
- Zarnestra (tipifarnib) / Kura Oncology
Enrollment change, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Jun 25, 2012
P1, N=22, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Withdrawn N=40 --> 22
- Zarnestra (tipifarnib) / Kura Oncology
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Jun 25, 2012
P1, N=22, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
N=40 --> 22 Active, not recruiting --> Completed
- Zarnestra (tipifarnib) / Kura Oncology
Enrollment change, Metastases: S9923 R115777 in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Jun 11, 2012
P2, N=62, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed N=50 --> 62
- Zarnestra (tipifarnib) / Kura Oncology
Trial completion, Metastases: S9923 R115777 in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Jun 11, 2012
P2, N=62, Completed, Sponsor: Southwest Oncology Group
N=50 --> 62 Active, not recruiting --> Completed
- Zarnestra (tipifarnib) / Kura Oncology
Trial completion, Metastases: S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (clinicaltrials.gov) - Jun 11, 2012
P2, N=58, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Zarnestra (tipifarnib) / Kura Oncology
Trial completion: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (clinicaltrials.gov) - Feb 15, 2012
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Zarnestra (tipifarnib) / Kura Oncology
Trial completion: S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - Jan 12, 2012
P2, N=296, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Zarnestra (tipifarnib) / Kura Oncology
Trial completion: Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme (clinicaltrials.gov) - Nov 22, 2011
P2, N=27, Completed, Sponsor: Institut Claudius Regaud
Active, not recruiting --> Completed Active, not recruiting --> Completed